Business Context and Reporting Period
This Form 8-K is filed by Neuralstem, Inc. (not Palisade Bio, Inc., as indicated in the metadata) on September 17, 2019, reporting an event that occurred on September 12, 2019. The company is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol CUR.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
- Board Resignation: William Oldaker resigned as a member of the Board of Directors, effective September 30, 2019.
- Reason for Departure: The resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on business performance, or discussion of risks and contingencies. The document is limited to the disclosure of the director's departure.
Investor Verification Checklist
- Verify the effective date of William Oldaker's resignation (September 30, 2019).
- Confirm whether the Board has appointed a replacement director to fill the vacancy.
- Check subsequent filings for any impact on the company's strategic direction or governance structure.